These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 33140861)

  • 21. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.
    Brasen CL; Christensen H; Olsen DA; Kahns S; Andersen RF; Madsen JB; Lassen A; Kierkegaard H; Jensen A; Sydenham TV; Madsen JS; Møller JK; Brandslund I
    Clin Chem Lab Med; 2021 Nov; 59(12):1988-1997. PubMed ID: 34455731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
    ;
    Cell; 2022 Mar; 185(5):916-938.e58. PubMed ID: 35216673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Volume in Vitro Diagnostic Proton NMR Spectroscopy of Human Blood Plasma for Lipoprotein and Metabolite Analysis: Application to SARS-CoV-2 Biomarkers.
    Lodge S; Nitschke P; Loo RL; Kimhofer T; Bong SH; Richards T; Begum S; Spraul M; Schaefer H; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2021 Feb; 20(2):1415-1423. PubMed ID: 33491459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses.
    Kwon JS; Kim JY; Kim MC; Park SY; Kim BN; Bae S; Cha HH; Jung J; Kim MJ; Lee MJ; Choi SH; Chung JW; Shin EC; Kim SH
    Am J Trop Med Hyg; 2020 Dec; 103(6):2412-2418. PubMed ID: 33124544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
    Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
    Front Immunol; 2021; 12():700782. PubMed ID: 34262570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
    D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
    PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
    Villar M; Urra JM; Rodríguez-Del-Río FJ; Artigas-Jerónimo S; Jiménez-Collados N; Ferreras-Colino E; Contreras M; de Mera IGF; Estrada-Peña A; Gortázar C; de la Fuente J
    Front Immunol; 2021; 12():730710. PubMed ID: 34566994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.
    Tovo PA; Garazzino S; Daprà V; Pruccoli G; Calvi C; Mignone F; Alliaudi C; Denina M; Scolfaro C; Zoppo M; Licciardi F; Ramenghi U; Galliano I; Bergallo M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan.
    Kashiwagi K; Maeda T; Yoshizawa S; Sato T; Aoki K; Ishii Y; Tateda K
    J Nippon Med Sch; 2021 Sep; 88(4):380-383. PubMed ID: 33250476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
    PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity.
    Passos FRS; Heimfarth L; Monteiro BS; Corrêa CB; Moura TR; Araújo AAS; Martins-Filho PR; Quintans-Júnior LJ; Quintans JSS
    Int Immunopharmacol; 2022 Mar; 104():108502. PubMed ID: 35063743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.